X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M | 2022-11-22 | TCDA | Orbimed Advisors LLC | Dir, 10% | S - Sale | $0.21 | -10,280,947 | 0 | -100% | -$2,205,635 | |||||
M | 2022-11-22 | TCDA | Bonita David P | Dir, 10% | S - Sale | $0.21 | -10,280,947 | 0 | -100% | -$2,205,635 | |||||
2022-11-23 | TCDA | Alpern Robert J | Dir | S - Sale | $0.21 | -131,879 | 0 | -100% | -$27,695 | ||||||
2022-11-21 | TCDA | Alpern Robert J | Dir | S - Sale | $0.23 | -27,584 | 131,879 | -17% | -$6,344 | ||||||
M | 2022-10-24 | TCDA | Venrock Healthcare Capital Partners Ii, L.P. | 10% | S - Sale | $0.54 | -6,451,540 | 3,751,406 | -63% | -$3,501,547 | |||||
M | 2022-10-18 | TCDA | Venrock Healthcare Capital Partners Ii, L.P. | 10% | P - Purchase | $10.68 | +351,866 | 10,202,946 | +4% | +$3,756,273 | |||||
M | 2022-10-13 | TCDA | Venrock Healthcare Capital Partners Ii, L.P. | 10% | P - Purchase | $11.68 | +174,966 | 9,851,080 | +2% | +$2,043,302 | |||||
M | 2022-10-11 | TCDA | Isern Brian M. | *possible member of 10% group, 10% | S - Sale | $12.32 | -360,000 | 5,563,493 | -6% | -$4,433,401 | |||||
M | 2022-10-07 | TCDA | Venrock Healthcare Capital Partners Ii, L.P. | 10% | P - Purchase | $11.91 | +134,214 | 9,676,114 | +1% | +$1,597,983 | |||||
2022-10-04 | TCDA | Venrock Healthcare Capital Partners Ii, L.P. | 10% | P - Purchase | $11.81 | +223,100 | 9,541,900 | +2% | +$2,634,811 | ||||||
M | 2022-09-30 | TCDA | Isern Brian M. | possible member of 10% group, 10% | S - Sale | $10.87 | -168,962 | 5,923,493 | -3% | -$1,836,632 | |||||
M | 2022-09-29 | TCDA | Venrock Healthcare Capital Partners Ii, L.P. | 10% | P - Purchase | $10.75 | +436,923 | 9,318,800 | +5% | +$4,697,070 | |||||
M | 2022-09-26 | TCDA | Venrock Healthcare Capital Partners Ii, L.P. | 10% | P - Purchase | $8.90 | +587,214 | 8,881,877 | +7% | +$5,225,028 | |||||
M | 2022-09-02 | TCDA | Venrock Healthcare Capital Partners Ii, L.P. | 10% | P - Purchase | $11.53 | +686,712 | 8,294,663 | +9% | +$7,918,744 | |||||
2022-08-30 | TCDA | Venrock Healthcare Capital Partners Ii, L.P. | 10% | P - Purchase | $12.20 | +50,000 | 7,607,951 | +1% | +$610,000 | ||||||
M | 2022-08-12 | TCDA | Isern Brian M. | possible member of 10% group, 10% | S - Sale | $13.50 | -284,939 | 10,434,820 | -3% | -$3,846,641 | |||||
2022-07-29 | TCDA | Venrock Healthcare Capital Partners Ii, L.P. | 10% | P - Purchase | $9.21 | +18,900 | 7,557,951 | 0% | +$174,069 | ||||||
M | 2022-07-21 | TCDA | Venrock Healthcare Capital Partners Ii, L.P. | 10% | P - Purchase | $9.26 | +74,199 | 7,539,051 | +1% | +$687,181 | |||||
M | 2022-07-18 | TCDA | Venrock Healthcare Capital Partners Ii, L.P. | 10% | P - Purchase | $9.18 | +150,000 | 7,464,852 | +2% | +$1,377,250 | |||||
M | 2022-07-12 | TCDA | Venrock Healthcare Capital Partners Ii, L.P. | 10% | P - Purchase | $9.88 | +94,573 | 7,314,852 | +1% | +$934,815 | |||||
M | 2022-07-01 | TCDA | Venrock Healthcare Capital Partners Ii, L.P. | 10% | P - Purchase | $9.61 | +88,200 | 7,220,279 | +1% | +$847,230 | |||||
M | 2022-06-28 | TCDA | Venrock Healthcare Capital Partners Ii, L.P. | 10% | P - Purchase | $9.76 | +62,870 | 7,132,079 | +1% | +$613,510 | |||||
M | 2022-06-22 | TCDA | Venrock Healthcare Capital Partners Ii, L.P. | 10% | P - Purchase | $10.37 | +492,020 | 7,069,209 | +7% | +$5,101,092 | |||||
2022-06-16 | TCDA | Venrock Healthcare Capital Partners Ii, L.P. | 10% | P - Purchase | $9.69 | +5,951 | 6,577,189 | 0% | +$57,665 | ||||||
M | 2022-06-10 | TCDA | Venrock Healthcare Capital Partners Ii, L.P. | 10% | P - Purchase | $8.57 | +118,054 | 6,571,238 | +2% | +$1,011,461 | |||||
M | 2022-06-07 | TCDA | Venrock Healthcare Capital Partners Ii, L.P. | 10% | P - Purchase | $9.65 | +588,024 | 6,453,184 | +10% | +$5,672,963 | |||||
M | 2022-06-02 | TCDA | Venrock Healthcare Capital Partners Ii, L.P. | 10% | P - Purchase | $9.16 | +190,871 | 5,865,160 | +3% | +$1,748,709 | |||||
M | 2022-04-26 | TCDA | Isern Brian M. | possible member of 10% group, 10% | S - Sale | $10.89 | -46,099 | 6,377,394 | -1% | -$502,132 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |